Security key
N69605108
Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (PHVS)
CUSIP: N69605108
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Ordinary Shares, par value Euro 0.12 per share
- Total 13F shares
- 45,040,180
- Total 13F value
- $792,712,813
- Share change
- +100,912
- SEC-reported price per share
- $17.60
- Number of holders
- 60
- Value change
- +$1,806,103
- Number of buys
- 27
- Number of sells
- 17
- Shares outstanding
- 69,889,980
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
60
Top holders
10
PHVS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Pharvaris N.V. SEC filings
Pharvaris N.V. company facts
Broader feeds
Reporting periods
Holder history for CUSIP N69605108
Recent filing periods:
Ownership snapshot
Top reported holders of PHVS - Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Venrock Healthcare Capita...
Disclosed value leader
GENERAL ATLANTIC, L.P.
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
13F
Lead comparable stake: 3.8%
13D/G row: Venrock Healthcare Capital Partners III, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Venrock Healthcare Capital Partners III, L.P. leads the comparable SEC ownership view at 3.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Venrock Healthcare Capital Partners III, L.P.'s linked filing trail.
Comparable ownership
Top 5
Venrock Healthcare Capital Partne...
3.8%
GENERAL ATLANTIC, L.P.
11%
FMR LLC
7.7%
Foresite Capital Management IV, LLC
6.3%
venBio Partners LLC
6.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
3.8%
|
$51,436,214
2,047,620 shares
|
$0 | 30 Jun 2025 |
| GENERAL ATLANTIC, L.P. |
13F
Company
|
11%
|
$118,240,656
7,531,252 shares
|
— | 31 Mar 2025 |
| FMR LLC |
13F
Company
|
7.7%
|
$84,707,309
5,395,370 shares
|
— | 31 Mar 2025 |
| Foresite Capital Management IV, LLC |
13F
Company
|
6.3%
|
$69,246,122
4,410,581 shares
|
— | 31 Mar 2025 |
| venBio Partners LLC |
13F
Company
|
6.1%
|
$67,342,073
4,289,304 shares
|
— | 31 Mar 2025 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
5.2%
|
$57,356,967
3,653,310 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
60
Shares
45,040,180
Rows available
60
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q3 2025 Across Filers
Q3 2025 holders
83
Q2 2025 holders
60
Holder diff
-23
| Investor | Q3 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend